Hostname: page-component-857557d7f7-nk9cn Total loading time: 0 Render date: 2025-11-22T13:25:27.457Z Has data issue: false hasContentIssue false
  • English
  • Français

Levomepromazine in the Treatment of Neuroleptic Resistant Psychotics

Published online by Cambridge University Press:  08 February 2018

Peter Payne  and
David Verinder
Peter Payne
Affiliation:
Brandon Hospital for Mental Diseases, Brandon, Manitoba, Canada
David Verinder
Affiliation:
Brandon Hospital for Mental Diseases, Brandon, Manitoba, Canada
Get access Rights & Permissions [Opens in a new window]

Extract

Levomepromazine, levo-3-methoxy-10(2' methyl-3'-dimethylamino-l' propyl) phenothiazine is a phenothiazine derivative which was isolated in the Rhone-Poulenc Laboratories and studied pharmacologically by Sigwald et al. (2) in 1956.

Information

Type
Original Articles
Information
Journal of Mental Science , Volume 106 , Issue 445 , October 1960 , pp. 1429 - 1431
Copyright
Copyright © Royal College of Psychiatrists, 1960 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable

References

1 Deschamps, A., and Madre, J., Psychiatric Therapy with a New Neuroleptic (R.P. 7044), La Presse Medicale, Vol. 65, 46; 1071.Google Scholar
2 Sigwald, J., et al., Activité d'une nouvelle phénothiazine en psychiatrie et en neurologie. Presse Médicale. 1 December, 1956.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.